Characteristics, treatment patterns, and prognostic factors in small cell lung cancer transformation of advanced non-small cell lung cancer with epidermal growth factor receptor mutation after tyrosine kinase inhibitor therapy

被引：0
|
作者：
Liao, Ying-Ting
Chiang, Chi-Lu
Sun, Ruei-Lin
Yeh, Yi-chen
Huang, Hsu-Ching
Shen, Chia-I
Tseng, Yen-Han
Luo, Yung-Hung
Chen, Yuh-Min
Whang-Peng, Jacqueline
机构：
[1] Taipei Vet Gen Hosp, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan
[3] Taipei Med Univ, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20569
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
    Hammerman, Peter S.
    Jaenne, Pasi A.
    Johnson, Bruce E.
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7502 - 7509
  • [22] Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
    Tsai, CM
    Chiu, CH
    Chou, TY
    Li, LH
    Hsiao, CY
    Chen, M
    Perng, RP
    Tsai, SF
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 641S - 641S
  • [23] Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy
    Bunn, Paul A., Jr.
    Dziadziuszko, Rafal
    Varella-Garcia, Marileila
    Franklin, WilburA.
    Witta, Samir E.
    Kelly, Karen
    Hirsch, Fred R.
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3652 - 3656
  • [24] PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy
    Makino, Akira
    Miyazaki, Anna
    Tomoike, Ayaka
    Kimura, Hiroyuki
    Arimitsu, Kenji
    Hirata, Masahiko
    Ohmomo, Yoshiro
    Nishii, Ryuichi
    Okazawa, Hidehiko
    Kiyono, Yasushi
    Ono, Masahiro
    Saji, Hideo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 1609 - 1613
  • [25] IMPACT OF EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER: A META-ANALYSIS
    Lee, C. K.
    Brown, C.
    Gralla, R.
    Hirsh, V.
    Inoue, A.
    Gebski, V.
    Yang, C. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 414 - 414
  • [26] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
  • [27] Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer
    Gao, Yuan
    Song, PingPing
    Li, Hui
    Guo, HongBo
    Jia, Hui
    Zhang, BaiJiang
    ONCOTARGETS AND THERAPY, 2016, 9 : 13 - 20
  • [28] Epidermal growth factor receptor in non-small cell lung cancer
    Prabhakar, Charles N.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 110 - 118
  • [29] Management of non-small cell lung cancer with resistance to epidermal growth factor receptor tyrosine kinase inhibitor: case discussion
    Zheng, Yuyan
    Zhou, Min
    Arulananda, Surein
    Um, Sang-Won
    Li, Hecheng
    JOURNAL OF THORACIC DISEASE, 2020, 12 (03) : 159 - 164
  • [30] Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
    Kurihara, Eisuke
    Shien, Kazuhiko
    Torigoe, Hidejiro
    Takeda, Tatsuaki
    Takahashi, Yuta
    Ogoshi, Yusuke
    Yoshioka, Takahiro
    Namba, Kei
    Sato, Hiroki
    Suzawa, Ken
    Yamamoto, Hiromasa
    Soh, Junichi
    Okazaki, Mikio
    Shien, Tadahiko
    Tomida, Shuta
    Toyooka, Shinichi
    ANTICANCER RESEARCH, 2019, 39 (04) : 1767 - 1775
12345